Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial

Cited by (335)

Items 101–200 of 335

1. Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies
   Li Du, Lin Chen, Fangfang Liu, Wenya Wang, Hongyun Huang · 2023 · International review of neurobiology
2. Alzheimer’s Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis
   Edward R. Blonz · 2017 · Journal of Alzheimer s Disease
3. Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis
   Bloom, George S., Lazo, John S., Norambuena, Andrés · 2018 · Neuropharmacology
4. The Link Between Diabetes Mellitus and Tau Hyperphosphorylation: Implications for Risk of Alzheimer's Disease
   Amy L Hobday, Mayur S. Parmar · 2021 · Cureus
5. Metabolic determinants of Alzheimer’s disease: A focus on thermoregulation
   Marine Tournissac, Manon Leclerc, Josue Valentin‐Escalera, Milène Vandal, Cristina R. Bosoi, Emmanuel Planel, Frédéric Calon · 2021 · Ageing Research Reviews
6. Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies
   Xiangyuan Meng, Hui Zhang, Zhenhu Zhao, Siyao Li, Xin Zhang, Ruihan Guo, Hui Li, Yiling Yuan, W Li, Qi Song et al. · 2025 · Molecular Medicine
7. Mitochondrial Dysfunction in Alzheimer’s Disease and Progress in Mitochondria-Targeted Therapeutics
   Padraig J. Flannery, Eugenia V. Trushina · 2019 · Current Behavioral Neuroscience Reports
8. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model
   María Clara Sellés, Juliana T.S. Fortuna, Maria F. Zappa-Villar, Yasmin P.R. de Faria, Amanda Santos de Souza, Cláudia Kimie Suemoto, Renata Elaine Paraízo Leite, Roberta Diehl Rodriguez, Lea T. Grinberg, Paula Cecilia Reggiani et al. · 2019 · Molecular Neurobiology
9. Effects of Intranasal Insulin Administration on Cerebral Blood Flow and Cognitive Performance in Adults: A Systematic Review of Randomized, Placebo-Controlled Intervention Studies
   Kevin M.R. Nijssen, Ronald P. Mensink, Peter J. Joris · 2022 · Neuroendocrinology
10. Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer’s Disease
    Ari Robinson, Irit Lubitz, Dana Atrakchi, Avital Licht-Murava, Pavel Katsel, Derek LeRoith, Sigal Liraz Zaltsman, Vahram H. Haroutunian, Michal Schnaider Beeri · 2019 · Journal of Molecular Neuroscience
11. Pharmacological Interventions to Attenuate Alzheimer’s Disease Progression: The Story So Far
    Firas H. Bazzari, Dalaal M. Abdallah, Hanan Salah El-Abhar · 2019 · Current Alzheimer Research
12. Intranasal insulin and orexins to treat age-related cognitive decline
    Jennifer M. Erichsen, Coleman B. Calva, Lawrence Patrick Reagan, Jim R. Fadel · 2021 · Physiology & Behavior
13. High-Fat Diets in Animal Models of Alzheimer’s Disease: How Can Eating Too Much Fat Increase Alzheimer’s Disease Risk?
    Josue Valentin‐Escalera, Manon Leclerc, Frédéric Calon · 2024 · Journal of Alzheimer s Disease
14. Outcomes and clinical implications of intranasal insulin administration to the central nervous system
    João C. P. Santiago, Manfred Hallschmid · 2019 · Experimental Neurology
15. The Role of Insulin Signaling in Hippocampal-Related Diseases: A Focus on Alzheimer’s Disease
    Qi Liu, Zixu Wang, Jing Cao, Yulan Dong, Yaoxing Chen · 2022 · International Journal of Molecular Sciences
16. Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences
    Timothy M. Baran, Feng Vankee Lin, Alzheimer’s Disease Neuroimaging Initiative · 2018 · Journal of Alzheimer s Disease
17. The Protective Effect of Insulin on Rat Cortical Neurons in Oxidative Stress and Its Dependence on the Modulation of Akt, GSK-3beta, ERK1/2, and AMPK Activities
    Irina O. Zakharova, Т. В. Соколова, Liubov V. Bayunova, Inna I. Zorina, Maria P. Rychkova, Alexander Olegovich Shpakov, Natalia F. Avrova · 2019 · International Journal of Molecular Sciences
18. Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
    Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding, Sepideh Afshar · 2021 · International Journal of Molecular Sciences
19. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
    Jacky Tran, Sneh Parekh, Julia Rockcole, Danielle Wilson, Mayur S. Parmar · 2024 · Life Sciences
20. Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
    Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, Sohee Moon, Hyo‐Bum Kwak, Dong‐Ho Park, Ju‐Hee Kang · 2023 · International Journal of Molecular Sciences
21. Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device
    Davide D’Angelo, Stefan Kooij, Frank M. Verhoeven, Fabio Sonvico, Cees J. M. van Rijn · 2022 · Journal of Advanced Research
22. Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases
    Germán Plascencia‐Villa, George L. Perry · 2023 · International Journal of Molecular Sciences
23. Targeting Insulin for Alzheimer’s Disease: Mechanisms, Status and Potential Directions
    Jung Hyun Lee, Jordan B. Jahrling, Larry A. Denner, Kelly T. Dineley · 2018 · Journal of Alzheimer s Disease
24. Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis
    Cong Long, Xuke Han, Yunjiao Yang, Tongyi Li, Qian Zhou, Qiu Chen · 2022 · Frontiers in Aging Neuroscience
25. Metabolic Syndrome and Cognitive Trajectories in the Framingham Offspring Study
    Katherine J. Bangen, Nicole M. Armstrong, Rhoda Au, Alden L. Gross · 2019 · Journal of Alzheimer s Disease
26. A consensus research agenda for optimising nasal drug delivery
    Ben Forbes, René Bommer, Jonathan Goole, Marie Hellfritzsch, Wilbur de Kruijf, Pierre Lambert, Grazia Caivano, Alain Regard, Francesca Schiaretti, Marie Trenkel et al. · 2020 · Expert Opinion on Drug Delivery
27. Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of life
    Stefano Rizza, Giacomo Piciucchi, Maria Mavilio, Susanna Longo, Martina Montagna, Riccardo Tatonetti, Alessandro Nucera, Massimo Federici · 2021 · Biomedicine & Pharmacotherapy
28. The evolution of Alzheimer’s disease: From mitochondria to microglia
    Fengguang Yang, Yulin Liang, Xu Wang, Jun-Ting Wang, Wei Gao, Qiu-yan Ye, Xueyuan Li, Yang Yu, Honglin Li · 2025 · Ageing Research Reviews
29. A metabolic perspective of late onset Alzheimer’s disease
    Miren Ettcheto, Amanda C. Cano, Oriol Busquets, Patrícia Regina Manzine, Elena Sánchez‐López, Ruben Dario Castro-Torres, Carlos Beas‐Zárate, Ester Verdaguer, Maria Luisa García, Jordi Olloquequi et al. · 2019 · Pharmacological Research
30. Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions
    Sini Toppala, Laura L. Ekblad, Jyrki M. P. Lötjönen, Semi Helin, Saija A. M. Hurme, Jarkko J. Johansson, Antti Jula, Mira Karrasch, Juha R. Koikkalainen, Hanna K. Laine et al. · 2019 · Journal of Alzheimer s Disease
31. Antidiabetic therapies and Alzheimer disease.
    Barbara B. Bendlin · 2019 · PubMed Central
32. Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?
    Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, Anna‐Sophie Thein, Jens Rovelt Andreasen, Barbara Cvenkel, Pete A. Williams, Augusto Azuara‐Blanco, Miriam Kolko · 2022 · Frontiers in Neuroscience
33. The volatile oil of Acorus tatarinowii Schott ameliorates Alzheimer's disease through improving insulin resistance via activating the PI3K/AKT pathway
    Junhao Huang, Zhiwei Xu, Chenshi Yu, Liu Liu, Liting Ji, Ping Qiu, Changyu Li, Xiaojie Zhou · 2024 · Phytomedicine
34. Novel calcium-related targets of insulin in hippocampal neurons
    Shaniya Maimaiti, Hilaree N. Frazier, Katie L. Anderson, Adam O. Ghoweri, Lawrence D. Brewer, Nada M. Porter, Olivier Thibault · 2017 · Neuroscience
35. Gastrointestinal hormones in regulation of memory
    Anwesha Mandal, Kedar S. Prabhavalkar, Lokesh Kumar Bhatt · 2018 · Peptides
36. Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
    Ritze, Yvonne, Kern, Werner, Ebner, Eva-Maria, Jahn, Serena, Benedict, Christian, Hallschmid, Manfred · 2018 · Frontiers in Endocrinology
37. Crosstalk between Alzheimer’s disease and diabetes: a focus on anti-diabetic drugs
    Golnaz Goodarzi, Sadra Samavarchi Tehrani, Saeed Ebrahimi Fana, Hemen Moradi‐Sardareh, Ghodratollah Panahi, Mahmood Maniati, Reza Meshkani · 2023 · Metabolic Brain Disease
38. Non-Invasive Techniques of Nose to Brain Delivery Using Nanoparticulate Carriers: Hopes and Hurdles
    Mansi Butola, Nidhi Nainwal · 2024 · AAPS PharmSciTech
39. Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale
    Brahyan Galindo Mendez, Jorge A. Trevino, Regina E. McGlinchey, Catherine B. Fortier, Vasileios‐Arsenios Lioutas, Péter Novák, Christos Socrates Mantzoros, Long H. Ngo, Vera Novak · 2020 · Contemporary Clinical Trials
40. Alzheimer’s Disease Treatment: The Search for a Breakthrough
    Allison Bethanne Reiss, Dalia Muhieddine, Berlin Jacob, Michael Mesbah, Aaron Pinkhasov, Irving H. Gomolin, Mark M. Stecker, Thomas Wısnıewskı, Joshua De Leon · 2023 · Medicina
41. Ellagic Acid: A Green Multi-Target Weapon That Reduces Oxidative Stress and Inflammation to Prevent and Improve the Condition of Alzheimer’s Disease
    Silvana Alfei, Guendalina Zuccari · 2025 · International Journal of Molecular Sciences
42. Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial
    Patrick J. Smith, Stephanie Mabe, Andrew Sherwood, Pudugramam Murali Doraiswamy, Kathleen Anne Welsh-Bohmer, James R. Burke, William E. Kraus, Pao‐Hwa Lin, Jeffrey N. Browndyke, Michael A. Babyak et al. · 2020 · Journal of Alzheimer s Disease
43. Sexual dimorphism in the peripheral metabolic homeostasis and behavior in the TgF344‐AD rat model of Alzheimer's disease
    Hemant Kumar Srivastava, Alexander Tate Lasher, Akash Nagarajan, Liou Y. Sun · 2023 · Aging Cell
44. Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer’s disease and normalized by treatment with anti-diabetic agents
    Pavel Katsel, Panos Roussos, Michal Schnaider Beeri, Miguel A. Gama-Sosa, Sam Gandy, Sonia Khan, Vahram H. Haroutunian · 2018 · PLoS ONE
45. Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort
    Marc D. Rudolph, Courtney L. Sutphen, Thomas C. Register, Christopher T. Whitlow, Kiran Kumar Solingapuram Sai, Timothy M. Hughes, James R. Bateman, Jeffrey L. Dage, Kristen A. Russ, Michelle M. Mielke et al. · 2024 · Alzheimer s & Dementia
46. Sex differences in metabolic phenotype and hypothalamic inflammation in the 3xTg-AD mouse model of Alzheimer’s disease
    Lisa S. Robison, Olivia J. Gannon, Abigail E. Salinero, Charly Abi‐Ghanem, Richard D. Kelly, David A. Riccio, Febronia Morcos Mansour, Kristen L. Zuloaga · 2023 · Biology of Sex Differences
47. Association of Alzheimer's dementia with oral bacteria, vitamin B12, folate, homocysteine levels, and insulin resistance along with its pathophysiology, genetics, imaging, and biomarkers
    Priyadarshi Prajjwal, Shahnaz Asharaf, Dhruvi Makhanasa, Aishwarya Yamparala, Halla Tariq, Soumya Aleti, Srikanth Gadam, Neel Vora · 2023 · Disease-a-Month
48. Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease
    Muna A. Adem, Boris Decourt, Marwan Noel Sabbagh · 2024 · Biomedicines
49. Neonatal Exposure to Anesthesia Leads to Cognitive Deficits in Old Age: Prevention with Intranasal Administration of Insulin in Mice
    Chun‐Ling Dai, Hengchang Li, Xin Yang Hu, Jin Zhang, Fei Liu, Khalid Iqbal, Cheng‐Xin Gong · 2020 · Neurotoxicity Research
50. Insulin and α-Tocopherol Enhance the Protective Effect of Each Other on Brain Cortical Neurons under Oxidative Stress Conditions and in Rat Two-Vessel Forebrain Ischemia/Reperfusion Injury
    Irina O. Zakharova, Liubov V. Bayunova, Inna I. Zorina, Т. В. Соколова, Alexander Olegovich Shpakov, Natalia F. Avrova · 2021 · International Journal of Molecular Sciences
51. Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer’s Disease?
    Vijay K. Hegde, Nikhil V. Dhurandhar, P. Hemachandra Reddy · 2019 · Journal of Alzheimer s Disease
52. Warm, Sweetened Milk at the Twilight of Immunity - Alzheimer’s Disease - Inflammaging, Insulin Resistance, M. paratuberculosis and Immunosenescence
    Coad Thomas Dow · 2021 · Frontiers in Immunology
53. Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease
    Ibtisam Mumtaz, Mir Owais Ayaz, Mohamad Sultan Khan, Umar Manzoor, Mohd Azhardin Ganayee, Aadil Qadir Bhat, Ghulam Hassan Dar, Badrah Saeed Ali Alghamdi, Anwar M. Hashem, Mohd Jamal Dar et al. · 2022 · Frontiers in Aging Neuroscience
54. Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease
    Punya Sachdeva, Kannan Badri Narayanan, Jitendra Kumar Sinha, Saurabh K. Gupta, Shampa Ghosh, Dr. Krishna Kumar Singh, Rakesh Bhaskar, Abdulmajeed G. Almutary, James H. Zothantluanga, Kranthi Kumar Kotta et al. · 2024 · Journal of Alzheimer s Disease
55. Mitochondrial dysfunction: A potential target for Alzheimer’s disease intervention and treatment
    Jia Ke, Qinfang Tian, Qixia Xu, Zhenqin Fu, Qiang Fu · 2021 · Drug Discovery Today
56. Hypothesis and Theory: Circulating Alzheimer's-Related Biomarkers in Type 2 Diabetes. Insight From the Goto-Kakizaki Rat
    Jamileh Movassat, Etienne Delangre, Junjun Liu, Yuchen Gu, Nathalie Janel · 2019 · Frontiers in Neurology
57. Emerging role of Metformin in Alzheimer’s disease: A translational view
    Juvenal A. Ríos, Juan Carlos Bórquez, Juan Alejandro Godoy, Juan Manuel Zolezzi, María Cristina Furrianca, Nibaldo C. Inestrosa · 2024 · Ageing Research Reviews
58. Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies
    Mini Dahiya, Monu Yadav, Chetan Goyal, Anil Kumar · 2025 · Inflammopharmacology
59. Glycation in Alzheimer’s Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions
    Sama Ayoub, Maryam Arabi, Yousef A. Al-Najjar, Ibrahim Laswi, Tiago F. Outeiro, Ali Châari · 2025 · Molecular Neurobiology
60. The Role of Nutrition in Individualized Alzheimer’s Risk Reduction
    Yasmin Amini, Nabeel Saif, Christine E. Greer, Hollie Hristov, Richard Isaacson · 2020 · Current Nutrition Reports
61. Epigenetic modifications of DNA and RNA in Alzheimer’s disease
    Paula Martínez-Feduchi, Peng Jin, Bing Yao · 2024 · Frontiers in Molecular Neuroscience
62. Molecular Mechanisms of Intranasal Insulin in SAMP8 Mice
    Elizabeth M. Rhea, Surabhi Nirkhe, Steven Nguyen, Sarah Pemberton, Theo K. Bammler, Richard Beyer, Michael L. Niehoff, John Edward Morley, Susan A. Farr, William A. Banks · 2019 · Journal of Alzheimer s Disease
63. PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains
    Naresh Damuka, Paul W. Czoty, Ashley Davis, Michael A. Nader, Susan H. Nader, Suzanne Craft, Shannon L. Macauley, Lindsey K. Galbo, Phillip M. Epperly, Christopher T. Whitlow et al. · 2020 · Molecules
64. Failure of the Brain Glucagon-Like Peptide-1-Mediated Control of Intestinal Redox Homeostasis in a Rat Model of Sporadic Alzheimer’s Disease
    Jan Homolak, Ana Babić Perhoč, Ana Knezović, Jelena Osmanović Barilar, Melita Šalković‐Petrišić · 2021 · Antioxidants
65. Type 3 Diabetes: Linking Insulin Resistance to Cognitive Decline
    Brooke E. Chapple, Emily Bayliss, Seth Woodfin, Marilyn Smith, Jeremiah Winter, William Moore · 2025 · Diseases
66. Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potential
    Gilliana Rozenblum, Karima Ait‐Aissa, G. E. D. Zahran, Mahdieh Alipour, Amal M. Sahyoun, Undral Munkhsaikhan, Adam Kassan, Tauheed Ishrat, Qi Wang, Ammaar H. Abidi et al. · 2025 · Alzheimer s & Dementia
67. Dementia Therapy Targeting Tau
    Luc Buée · 2019 · Advances in experimental medicine and biology
68. Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease
    Amy Woodfield, Tatiana Gonzales, Erik Helmerhorst, Simon Matthew Laws, Philip Newsholme, Tenielle Porter, Giuseppe Verdile · 2022 · International Journal of Molecular Sciences
69. Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
    Dana Britt DiBenedetti, Heather L. Menne, Russ Paulsen, Holly B. Krasa, George Vradenburg, Meryl Comer, Leigh F. Callahan, John B. Winfield, Michele H. Potashman, Kim A. Heithoff et al. · 2023 · Neurology and Therapy
70. The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies
    Madia Lozupone, Vittorio Dibello, Rodolfo Sardone, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Ilaria Bortone, Roberta Stallone, Mario Altamura, Antonello Bellomo et al. · 2023 · Expert Opinion on Drug Discovery
71. Inhibitory Activity of Insulin on Aβ Aggregation Is Restricted Due to Binding Selectivity and Specificity to Polymorphic Aβ States
    Michal Baram, Yifat Miller · 2020 · ACS Chemical Neuroscience
72. Association between abnormal glycolipid level and cognitive dysfunction in drug-naïve patients with bipolar disorder
    Yan Qiu, Sujuan Li, Ziwei Teng, Yuxi Tan, Xuelei Xu, Min Yang, Ziru Zhao, Jieyu Liu, Hui Tang, Hui Xiang et al. · 2021 · Journal of Affective Disorders
73. Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging
    Erin E. Sundermann, Kristine Mace Erlandson, Caitlin N. Pope, Anna Rubtsova, Jessica L. Montoya, Alison A. Moore, Catia Marzolini, Kelly Kathleen O’Brien, Savita G. Pahwa, Brendan A. I. Payne et al. · 2019 · AIDS Research and Human Retroviruses
74. Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review
    Benjamin Kioussis, Camilla S.L. Tuttle, Daniel S. Heard, Brian Keith Kennedy, Nicola T. Lautenschlager, Andrea Britta Maier · 2021 · Ageing Research Reviews
75. Glucose-lowering drugs, cognition, and dementia: The clinical evidence
    Che‐Yuan Wu, Lila R. Shapiro, Michael Ouk, Bradley J. MacIntosh, Sandra E. Black, Baiju R. Shah, Walter Swardfager · 2022 · Neuroscience & Biobehavioral Reviews
76. Insulin Inhibits Aβ42 Aggregation and Prevents Aβ42-Induced Membrane Disruption
    Kaho Long, Thomas Williams, Brigita Urbanc · 2019 · Biochemistry
77. The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability
    Christine Girges, Nirosen Vijiaratnam, Dilan S. Athauda, Grace Auld, Sonia Gandhi, Thomas Foltynie · 2021 · Drugs & Aging
78. Nasal insulin administration does not affect hepatic glucose production at systemic fasting insulin levels
    Plomgaard, Peter, Hansen, Jakob S., Ingerslev, Bodil, Clemmesen, Jens O., Secher, Niels H., van Hall, Gerrit, Fritsche, Andreas, Weigert, Cora, Lehmann, Rainer, Häring, Hans‐Ulrich et al. · 2019 · Diabetes, Obesity and Metabolism
79. Miracle fruit seed as a potential supplement for the treatment of learning and memory disorders in Alzheimer’s disease
    Xueyan Huang, Lu‐Lu Xue, Ting‐Bao Chen, Li‐Ren Huangfu, Ting‐Hua Wang, Liu‐Lin Xiong, Changyin Yu · 2023 · Frontiers in Pharmacology
80. Intranasal insulin treatment modulates the neurotropic, inflammatory, and oxidant mechanisms in the cortex and hippocampus in a low-grade inflammation model
    Kellen Ugioni Simon, Elias Wiggers Neto, Natália dos Santos Tramontin, Paula Bortoluzzi Canteiro, Bárbara da Costa Pereira, Rubya Pereira Zaccaron, Paulo César Lock Silveira, Alexandre Pastoris Muller · 2019 · Peptides
81. The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study
    Won Jun Kim, Jung Hyun Noh, Kyungdo Han, Cheol‐Young Park · 2021 · Journal of Alzheimer s Disease
82. Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
    Xiao‐Yu Liu, Ni Zhang, Sheng‐Xiao Zhang, Ping Xu · 2021 · European Journal of Neuroscience
83. Analysis of risk factors for depression in Alzheimer’s disease patients
    Hai Yang, Wenjuan Hong, Le Chen, Yong Kang Tao, Ziyi Peng, Huadong Zhou · 2020 · International Journal of Neuroscience
84. Review of Associations of Diabetes and Insulin Resistance With Brain Health in Three Harmonised Cohort Studies of Ageing and Dementia
    Roshni Biswas, Ana Werneck Capuano, Rupal I. Mehta, Lisa Laverne Barnes, David Bennett, Zoe Arvanitakis · 2025 · Diabetes/Metabolism Research and Reviews
85. Brain-targeted intranasal delivery of biologics: a perspective for Alzheimer's disease treatment
    Huan Li, Xiaoxia Shen, Beiyu Zhang, Yunan Li, Cameron Alexander, Peter Harvey, Zheying Zhu · 2025 · RSC Pharmaceutics
86. New advances in insulin products
    Kuldeep Rajpoot, Muktika Tekade, Mukesh Chandra Sharma, Nagashekhara Molugulu, Rakesh Kumar Tekade · 2020 · Elsevier eBooks
87. Breakdown of the blood–brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?
    Corey J. Frank, Ewan C. McNay · 2021 · Journal of Neuroendocrinology
88. Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus
    Ayesha Fauzi, Ewen Se Thoe, Tang Yin Quan, Adeline Chia Yoke Yin · 2023 · Journal of Diabetes and its Complications
89. Nonesterified fatty acids, cognitive decline, and dementia
    Kenneth Jay Mukamal · 2019 · Current Opinion in Lipidology
90. Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort
    Annabelle Chambers, Joanna J. Bury, Thaı́s Minett, Connor Duncan Richardson, Carol Brayne, Paul G. Ince, Pamela J. Shaw, Claire J. Garwood, Paul Roy Heath, Julie E. Simpson et al. · 2020 · Journal of Neuropathology & Experimental Neurology
91. Directly Reprogrammed Human Neurons to Understand Age-Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration
    Camila Gudenschwager, Isadora Chavez, C. Cárdenas, C. González-Billault · 2021 · Oxidative Medicine and Cellular Longevity
92. Local Delivery Strategies for Peptides and Proteins into the CNS: Status Quo, Challenges, and Future Perspectives
    Weizhou Yue, Jie Shen · 2023 · Pharmaceuticals
93. The Autophagic and Apoptotic Death of Forebrain Neurons of Rats with Global Brain Ischemia Is Diminished by the Intranasal Administration of Insulin: Possible Mechanism of Its Action
    Irina O. Zakharova, Liubov V. Bayunova, Daria K. Avrova, A. Tretyakova, Alexander Olegovich Shpakov, Natalia F. Avrova · 2024 · Current Issues in Molecular Biology
94. Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes
    Asya Petkova, Ilona Kubajewska, Alexandra Vaideanu, Andreas G. Schätzlein, Ijeoma Florence Uchegbu · 2022 · Pharmaceutics
95. Circadian changes in Alzheimer's disease: Neurobiology, clinical problems, and therapeutic opportunities.
    Karlo Toljan, J. Homolak · 2021 · Handbook of Clinical Neurology
96. Alzheimer’s disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities
    Krzysztof Bednarz, Joanna S. Siuda · 2021 · Neurologia i Neurochirurgia Polska
97. The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias
    Chuyao Huang, Zhenwen Wei, Ningxiang Zheng, Jingsi Yan, Jiayu Zhang, Xinyi Ye, Wei Zhao · 2025 · Alzheimer s & Dementia
98. Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer’s Disease
    Himan Mohamed-Mohamed, Victoria García‐Morales, Encarnacion Sanchez-Lara, Anabel González‐Acedo, Teresa Pardo-Moreno, María Isabel Tovar-Gálvez, Lucía Melguizo‐Rodríguez, Juan José Ramos‐Rodríguez · 2023 · Neurology International
99. Blood DNA methylation signature for incident dementia: Evidence from longitudinal cohorts
    Wei Zhang, Juan I. Young, Lissette Gomez, Michael A. Schmidt, David Lukacsovich, Brian W. Kunkle, X. Steven Chen, Eden R. Martin, Lily Wang · 2025 · Alzheimer s & Dementia
100. Adenovirus 36 improves glycemic control and markers of Alzheimer's disease pathogenesis
     Vijay K. Hegde, Murali Vijayan, Subodh Kumar, Md Akheruzzaman, Neha A. Sawant, Nikhil V. Dhurandhar, P. Hemachandra Reddy · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease